{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-100076","form_type":"8-K","ticker":"CVRX","cik":"0001235912","company_name":"CVRx, Inc.","filed_at":"2021-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.440106+00:00","generated_at":"2026-06-29T22:22:36.408458+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"CVRx Q2 revenue up 150% to $3.1M; IPO nets $133.3M","bullets":["Total revenue $3.1M (+150% YoY); U.S. HF revenue $2.0M (from $65K).","Net loss $17.7M (incl. $11.4M non-cash warrant expense); cash $47.1M.","IPO closed July 2; net proceeds ~$133.3M; 8.05M shares at $18.","Full-year 2021 revenue guidance $13.3-13.9M; Q3 revenue $3.3-3.6M.","Active implanting centers increased to 31; Martha Shadan appointed; first BATwire procedure performed."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-100076","json":"https://secwatch.observer/filing/0001104659-21-100076.json","markdown":"https://secwatch.observer/filing/0001104659-21-100076.md","text":"https://secwatch.observer/filing/0001104659-21-100076.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1235912/000110465921100076/0001104659-21-100076-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1235912/000110465921100076/tm2123927d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T22:22:36.408458+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}